204 related articles for article (PubMed ID: 37283472)
1. Experimental systems for the analysis of mutational signatures: no 'one-size-fits-all' solution.
Ivanov D; Hwang T; Sitko LK; Lee S; Gartner A
Biochem Soc Trans; 2023 Jun; 51(3):1307-1317. PubMed ID: 37283472
[TBL] [Abstract][Full Text] [Related]
2. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
Meier B; Volkova NV; Gerstung M; Gartner A
DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
[TBL] [Abstract][Full Text] [Related]
3. Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair.
Phillips DH
DNA Repair (Amst); 2018 Nov; 71():6-11. PubMed ID: 30236628
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns.
Sørensen SG; Shrikhande A; Poulsgaard GA; Christensen MH; Bertl J; Laursen BE; Hoffmann ER; Pedersen JS
Elife; 2023 Mar; 12():. PubMed ID: 36883553
[TBL] [Abstract][Full Text] [Related]
5. Two main mutational processes operate in the absence of DNA mismatch repair.
Németh E; Lovrics A; Gervai JZ; Seki M; Rospo G; Bardelli A; Szüts D
DNA Repair (Amst); 2020 May; 89():102827. PubMed ID: 32126497
[TBL] [Abstract][Full Text] [Related]
6. DNA Repair Footprint Uncovers Contribution of DNA Repair Mechanism to Mutational Signatures.
Wojtowicz D; Leiserson MDM; Sharan R; Przytycka TM
Pac Symp Biocomput; 2020; 25():262-273. PubMed ID: 31797602
[TBL] [Abstract][Full Text] [Related]
7. A Compendium of Mutational Signatures of Environmental Agents.
Kucab JE; Zou X; Morganella S; Joel M; Nanda AS; Nagy E; Gomez C; Degasperi A; Harris R; Jackson SP; Arlt VM; Phillips DH; Nik-Zainal S
Cell; 2019 May; 177(4):821-836.e16. PubMed ID: 30982602
[TBL] [Abstract][Full Text] [Related]
8. Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers.
Farmanbar A; Firouzi S; Kneller R; Khiabanian H
J Transl Med; 2022 Feb; 20(1):65. PubMed ID: 35109853
[TBL] [Abstract][Full Text] [Related]
9. Validating the concept of mutational signatures with isogenic cell models.
Zou X; Owusu M; Harris R; Jackson SP; Loizou JI; Nik-Zainal S
Nat Commun; 2018 May; 9(1):1744. PubMed ID: 29717121
[TBL] [Abstract][Full Text] [Related]
10. RepairSig: Deconvolution of DNA damage and repair contributions to the mutational landscape of cancer.
Wojtowicz D; Hoinka J; Amgalan B; Kim YA; Przytycka TM
Cell Syst; 2021 Oct; 12(10):994-1003.e4. PubMed ID: 34375586
[TBL] [Abstract][Full Text] [Related]
11. The repertoire of mutational signatures in human cancer.
Alexandrov LB; Kim J; Haradhvala NJ; Huang MN; Tian Ng AW; Wu Y; Boot A; Covington KR; Gordenin DA; Bergstrom EN; Islam SMA; Lopez-Bigas N; Klimczak LJ; McPherson JR; Morganella S; Sabarinathan R; Wheeler DA; Mustonen V; ; Getz G; Rozen SG; Stratton MR;
Nature; 2020 Feb; 578(7793):94-101. PubMed ID: 32025018
[TBL] [Abstract][Full Text] [Related]
12. Mutational signatures are jointly shaped by DNA damage and repair.
Volkova NV; Meier B; González-Huici V; Bertolini S; Gonzalez S; Vöhringer H; Abascal F; Martincorena I; Campbell PJ; Gartner A; Gerstung M
Nat Commun; 2020 May; 11(1):2169. PubMed ID: 32358516
[TBL] [Abstract][Full Text] [Related]
13. Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer.
Kim YA; Wojtowicz D; Sarto Basso R; Sason I; Robinson W; Hochbaum DS; Leiserson MDM; Sharan R; Vadin F; Przytycka TM
Genome Med; 2020 May; 12(1):52. PubMed ID: 32471470
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms underlying mutational signatures in human cancers.
Helleday T; Eshtad S; Nik-Zainal S
Nat Rev Genet; 2014 Sep; 15(9):585-98. PubMed ID: 24981601
[TBL] [Abstract][Full Text] [Related]
15. Mutational signature SBS8 predominantly arises due to late replication errors in cancer.
Singh VK; Rastogi A; Hu X; Wang Y; De S
Commun Biol; 2020 Aug; 3(1):421. PubMed ID: 32747711
[TBL] [Abstract][Full Text] [Related]
16. An overview of mutational and copy number signatures in human cancer.
Steele CD; Pillay N; Alexandrov LB
J Pathol; 2022 Jul; 257(4):454-465. PubMed ID: 35420163
[TBL] [Abstract][Full Text] [Related]
17. Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapy.
Hatakeyama K; Nagashima T; Ohshima K; Ohnami S; Ohnami S; Shimoda Y; Serizawa M; Maruyama K; Naruoka A; Akiyama Y; Urakami K; Kusuhara M; Mochizuki T; Yamaguchi K
Cancer Sci; 2019 Aug; 110(8):2620-2628. PubMed ID: 31152682
[TBL] [Abstract][Full Text] [Related]
18. C. elegans whole-genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiency.
Meier B; Cooke SL; Weiss J; Bailly AP; Alexandrov LB; Marshall J; Raine K; Maddison M; Anderson E; Stratton MR; Gartner A; Campbell PJ
Genome Res; 2014 Oct; 24(10):1624-36. PubMed ID: 25030888
[TBL] [Abstract][Full Text] [Related]
19. Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis.
Petljak M; Alexandrov LB; Brammeld JS; Price S; Wedge DC; Grossmann S; Dawson KJ; Ju YS; Iorio F; Tubio JMC; Koh CC; Georgakopoulos-Soares I; Rodríguez-Martín B; Otlu B; O'Meara S; Butler AP; Menzies A; Bhosle SG; Raine K; Jones DR; Teague JW; Beal K; Latimer C; O'Neill L; Zamora J; Anderson E; Patel N; Maddison M; Ng BL; Graham J; Garnett MJ; McDermott U; Nik-Zainal S; Campbell PJ; Stratton MR
Cell; 2019 Mar; 176(6):1282-1294.e20. PubMed ID: 30849372
[TBL] [Abstract][Full Text] [Related]
20. Mutation Signatures Depend on Epigenomic Contexts.
Coleman N; De S
Trends Cancer; 2018 Oct; 4(10):659-661. PubMed ID: 30292349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
